Objective. The aim of this review was to synthesize the psychometric properties of generic preference-based measures (PBMs) of health-related quality of life (HRQL) in Amyotrophic Lateral Sclerosis (ALS). Methods. A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Four databases were searched from inception to April 2019: OVID Medline, Embase, PsycINFO, and CINAHL. Studies were included if (1) the sample represented individuals with ALS, (2) a generic PBM was utilized and reported on, and (3) information on the psychometric property of a generic PBM was provided. Results. Ninety-one articles were screened, and 39 full-text articles were reviewed. Seven full-text ...
This paper uses the standard error of measurement (SEM) and the standard error of the difference (S(...
AbstractObjectivesSome argue that generic preference-based measures (PBMs) are not sensitive to cert...
Objectives: Using the Wilson and Cleary model linking clinical variables to quality of life, we expl...
Nicole Peters,1 Vanina Dal Bello-Haas,1 Tara Packham,1 Marvin Chum,2 Colleen O’Connell,3 Wendy S Joh...
(1) Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. There is no evid...
INTRODUCTION: The Amyotrophic Lateral Sclerosis (ALS)-Specific Quality of Life instrument and its re...
The measurement of functioning and well-being from the perspective of the patient has in recent year...
The measurement of functioning and well-being from the perspective of the patient has in recent year...
BACKGROUND: There is no generally accepted instrument for measuring quality of life (QOL) in patient...
INTRODUCTION: The ALS Specific Quality of Life instrument and its revised version (ALSSQOL, ALSSQOL-...
Abstract Background The study aimed to appraise the health-related quality of life (HRQoL) measured ...
Improving quality of life (QoL) is central to amyotrophic lateral sclerosis (ALS) treatment. This Ge...
Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative rare disease characterized by sy...
OBJECTIVE: To systematically identify and appraise evidence on associations between psychological fa...
The Schedule for the Evaluation of the Individual Quality of Life-Direct Weighting (SEIQoL-DW) has b...
This paper uses the standard error of measurement (SEM) and the standard error of the difference (S(...
AbstractObjectivesSome argue that generic preference-based measures (PBMs) are not sensitive to cert...
Objectives: Using the Wilson and Cleary model linking clinical variables to quality of life, we expl...
Nicole Peters,1 Vanina Dal Bello-Haas,1 Tara Packham,1 Marvin Chum,2 Colleen O’Connell,3 Wendy S Joh...
(1) Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. There is no evid...
INTRODUCTION: The Amyotrophic Lateral Sclerosis (ALS)-Specific Quality of Life instrument and its re...
The measurement of functioning and well-being from the perspective of the patient has in recent year...
The measurement of functioning and well-being from the perspective of the patient has in recent year...
BACKGROUND: There is no generally accepted instrument for measuring quality of life (QOL) in patient...
INTRODUCTION: The ALS Specific Quality of Life instrument and its revised version (ALSSQOL, ALSSQOL-...
Abstract Background The study aimed to appraise the health-related quality of life (HRQoL) measured ...
Improving quality of life (QoL) is central to amyotrophic lateral sclerosis (ALS) treatment. This Ge...
Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative rare disease characterized by sy...
OBJECTIVE: To systematically identify and appraise evidence on associations between psychological fa...
The Schedule for the Evaluation of the Individual Quality of Life-Direct Weighting (SEIQoL-DW) has b...
This paper uses the standard error of measurement (SEM) and the standard error of the difference (S(...
AbstractObjectivesSome argue that generic preference-based measures (PBMs) are not sensitive to cert...
Objectives: Using the Wilson and Cleary model linking clinical variables to quality of life, we expl...